VASCULITIS
VASCULITIS
VASCULITIS
Goals
Overview
Clinical patterns
Diagnostic aids
Treatment paradigms
Cases and questions
Introduction
Vasculitis: Primary or
Secondary?
Secondary: Vasculitis is a
complication of another disease or
toxin (e.g. RA, infection, malignancy)
Classification of Vasculitis
No universally accepted
classification system
Vessel size
Histopathology
Dominant organ involvement
Overlap
Classification of Vasculitis
Large Vessel
Giant cell arteritis
Takayasus
Medium Vessel
Polyarteritis Nodosa
Kawasakis
Small Vessel
Wegeners, Microscopic polyangitis,
Henoch-Scholein purpura, Cryoglobulemic,
hypersensitivity
Classification of Vasculitis
Unexplained ischemia:
Claudication, limb ischemia, angina,
TIA, stroke, mesenteric ischemia,
cutaneous ischemia
Especially in a young individual
Multiorgan dysfunction:
Systemically ill patient
Other suggestive features
Glomerulonephritis
Palpable purpura
Peripheral neuropathy
Established autoimmune disease
Sepsis
Drug toxicity
Malignancy
Coagulopathy
General Approach to
Diagnosis
Attempt to exclude other
processes
Consider the age, gender,
ethnicity of the patient
Determine which organ systems
are involved
Estimate the size of the vessels
involved
Demographic Associations
Clues to Diagnosis
Clues to Diagnosis
Clues to Diagnosis
Clues to Diagnosis
Clues to Diagnosis
Approach to Diagnosis:
ANCAs 101
p-ANCA
Approach to Diagnosis:
Biopsy
Approach to Diagnosis:
Angiogram
If biopsy is impractical
Important in large vessel vasculitis
Patient with abdominal pain
Renal or mesenteric vasculitis
Approach to Diagnosis:
Angiogram
Prognosis
Treatment
Determined by:
Type and severity of organ involvement
Rate of disease progression
Corticosteroids
Usually 1mg/kg initially
Pulse dose corticosteroids
Immunosuppressive therapy
Cytoxan, Methotrexate, Imuran
Case
Case
Case
Case
Henoch-Schonlein Purpura
Henoch-Schonlein Purpura
GI involvement in 85%
Severe cramping, pain, nausea,
vomiting, bleeding
Major hemorrage or intussuseption
is an uncommon but life-threatening
complication in children
Henoch-Schonlein Purpura
Henoch-Schonlein Purpura
Uncommon
Testicular involvement
Pulmonary hemorrhage
CNS complications
Henoch-Schonlein Purpura
Treatment
Supportive measures
Corticosteroids for GI vasculitis and
hemorrhage
? CS early in nephritis
Case
Case
Case
Case
She is treated with empiric antibiotics over 3
days with no improvement in symptoms.
What is the most likely diagnosis:
A. Eosinophilic bronchitis
B. Idiopathic hypereosinophilic syndromes
C. Churg-Strauss syndrome
D. Wegeners granulomatosis
E. Polyarteritis nodosa
Case
She is treated with empiric antibiotics over 3
days with no improvement in symptoms.
What is the most likely diagnosis:
A. Eosinophilic bronchitis
B. Idiopathic hypereosinophilic syndromes
C. Churg-Strauss syndrome
D. Wegeners granulomatosis
E. Polyarteritis nodosa
Churg-Strauss Vasculitis
Prior asthma
Asthma
Eosinophilia (>10%)
Mono/ Polyneuropathy
Pulmonary Infiltrates Non-fixed
Paranasal sinus abnormality
Extravascular eosinophils
Churg-Strauss Vasculitis
Churg-Strauss Vasculitis
Case
Case
Wegeners Granulomatosis
Wegeners Granulomatosis
Non-specific abnormalities
Wegeners Granulomatosis
Criteria: 2 or more
Nasal/oral ulcers OR purulent/
bloody discharge
Abnormal CXR - nodules, focal
infiltrates, cavities
Abnormal urine sediment
(microhematuria, RBC casts)
Granulomatous inflammation
Wegeners Granulomatosis
c-ANCA
Open biopsy
Paranasal, nasal, larynx, lung
Renal biopsy rarely distinctive enough to
be definitive
Wegeners Granulomatosis
Outcomes:
Intervention
Survival
None
50% at 5 months
Glucocorticoids
50% at 1 year
GCS + Cytoxan
80% at 8 years
WG
Asthma
+++
uncommon
Eosinophils
+++
occ /modest
Atopy
+++
uncommon
uncommon
Pulmonary nodules
occasional
++
Renal failure
++
Case
Case
Polyarteritis Nodosa
Polyarteritis Nodosa
Any age
Peak years: 30-60
M:F Ratio 2:1
Polyarteritis Nodosa
Polyarteritis Nodosa
PAN-Diagnosis
Case
A.
B.
C.
D.
E.
Case
A.
B.
C.
D.
E.
Takayasus Arteritis
Large vessel
Unknown etiology
Aorta/branches
Pulseless Disease
Takayasus Arteritis
Granulomatous Panarteritis
Takayasus Arteritis
Takayasus Arteritis
Claudication
Transient cerebral ischemia/ stroke
Renal artery hypertension
CHF
Angina
MI
Mesenteric vascular insufficiency
Takayasus Arteritis
Case
A.
B.
C.
D.
E.
Case
A.
B.
C.
D.
E.
Lab
Biopsy
Vascular involvement not uniform
Length ?: If normal TA exam, obtain 3-5
cm sample and examine at multiple
levels
Negative biopsy
Consider contralateral bx if first bx
normal
When ? ..ASAP
Prednisone 1mg/kg/d
Taper 10%/month after Sx/lab
resolved
Slow taper at 15 mg/d
Lab and Sx
Long term steroids
Questions?